Bitcoin Edges Lower as Geopolitical Optimism Clashes with Persistent ETF Outflows Enhanced Games Trump JrBacked Steroid Olympics Set to Debut in Las Vegas Gold Prices Face Potential SellOff as Rate Hike Expectations Intensify Amid Stagflation Worries Consumer Strength Lifts Wall Street as Energy and Financials Drag Portugals Meo Sues State for 82 Million Over Huawei 5G Ban GPCR Q1 2026 Earnings NarrowerthanExpected Loss as Pipeline Progress Continues PLDT Inc Q1 2026 Earnings EPS Falls Slightly Short Amid Stable Operations Capital Bancorp Inc Q1 2026 Earnings Earnings Miss Expectations Shares Edge Higher SUIG Q1 2026 Earnings Staggering Earnings Miss Raises Serious Concerns DMC Global BOOM Q1 2026 Earnings Surprise EPS Beat Amid Persistent Headwinds Commerce Bancshares CBSH Edges Lower Amid Modest Selling Pressure bioAffinity Technologies BIAF Holds Steady at 165 as Consolidation Persists JIN Medical International ZJYL Gains 371 as Shares Test Key Resistance at 250 Eaton Corporation ETN Gains Momentum Technical and Fundamental Drivers Behind the Uptrend PDD Holdings Shares Drop Sharply Key Support Levels Under Pressure 21Shares Solana ETF TSOL Holds Near Support Amid Modest Decline ByteDance Deploys Special Stock Incentives for AI Team Amid Intensifying Talent War ILMN Q1 2026 Earnings EPS Beat Driven by Operational Efficiency ECB Tightening Dilemma Market Expectations Already Curbing Lending AnheuserBusch InBev Shares Slip After Quarterly Sales Miss Market Expectations ACEL Q1 2026 Earnings Strong Earnings Beat Drives 548 Surprise Yet Stock Slides Altria Group Edges Higher as Defensive Positioning Attracts Steady Inflows UDR Inc UDR Declines 141 as Shares Approach Key Support Level Core Scientific Warrants CORZZ Slide 322 as Support Levels Come into Focus Xunlei XNET Edges Higher Testing Key Resistance Near 631 Compass Therapeutics CMPX Holds Near Support Amid Subtle Downside Pressure Beazer Homes BZH Climbs 17 as Homebuilder Sector Finds Footing Lattice Semiconductor LSCC Holds Near Support After Mild Pullback Key Levels to Watch Reviva Pharmaceuticals RVPH Slips 141 as Stock Tests Key Support at 040